PRWeek Healthcare & Pharma Communications Awards: entry deadline extended

The deadline for entering PRWeek's prestigious Healthcare & Pharma Communications Awards has been extended.

The standard entry deadline is now 25 November, with a late-entry deadline of 26 January 2023.

The Awards, now in their third year, recognise the best agencies, in-house teams, campaigns and individuals in the fast-growing healthcare and pharmaceutical industries. Click here to enter.

Given the spate of mergers and acquisitions deals among healthcare and pharma comms agencies, a new category of Best Healthcare Agency M&A Deal has been added (see a full list of categories below).

The Awards cover entries from across the EMEA region.

PRWeek UK editor John Harrington said: "Healthcare and pharma comms are on the up, and are more important than ever - and we want to recognise the best of the best. Enter PRWeek's Healthcare & Pharma Comms Awards to be acknowledged as a leader in the field among clients, would-be employees and your peers, while giving your team a much-needed boost."

For more details and to enter, click here. Any questions, please email rob.archer-smith@haymarket.com.

Full list of categories

Campaign/Project Categories

  • Best Healthcare Product Launch
  • Best Pharmaceutical Product Launch (OTC)
  • Best Pharmaceutical Product Launch (non-OTC)
  • Best Healthcare/Pharma Crisis Comms Response
  • Best Public Health Awareness Campaign
  • Best Use of Content in a Healthcare/Pharma Campaign
  • Best Use of Media Relations in a Healthcare/Pharma Campaign
  • Best Use of Public Affairs in a Healthcare/Pharma Campaign
  • Best Use of Social Media and/or Influencers in a Healthcare/Pharma Campaign

Individual Categories

  • Best Healthcare/Pharma Comms Professional (agency)
  • Healthcare/Pharma Comms Newcomer of the Year
  • Best Healthcare/Pharma Comms Professional (in-house)

Team/Agency Categories

  • Best Healthcare/Pharma Comms Agency
  • Best Healthcare/Pharma In-house Comms Team
  • Best Healthcare Agency Merger & Acquisition Deal

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Recommended for you

Recommended for you

Explore further

Latest